View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar, Budapest, Diós árok 1/C, 1125
Open access

Absztrakt

Az obstruktív tüdőbetegségek világszerte jelentős népegészségügyi problémát jelentenek, magas prevalenciájuk és a társadalmat érintő nagy szocioökonómiai költségeik miatt. Az asthma bronchiale és a krónikus obstruktív tüdőbetegség krónikus légúti gyulladással járó betegségek, amelyeket légúti obstrukció jellemez, azonban külön nozológiai entitások, figyelembe véve kialakulásukat, diagnosztikájukat, a terápiás megfontolásokat és prognosztikai jellemzőiket. A két betegség együttesen is előfordulhat, vagy az egyik állapot képes a másik jellemzőit felvéve, abba átalakulni. Ezt a kevert asthma-COPD fenotípust nevezzük asthma-COPD overlap szindrómának, amelyet úgy jellemeznek, hogy olyan perzisztáló légúti áramláskorlátozottsággal járó betegség, amely rendelkezik mind az asthma, mind a krónikus obstruktív tüdőbetegség egyes jellemzőivel. A szindróma az elmúlt években jelentős figyelmet kapott, azonban a betegek nagy része mostanáig kizárásra került a klinikai és légúti gyógyszer-hatásossági vizsgálatokból, így a jól meghatározott klinikai jellemzők és a megfelelő terápia továbbra sem ismertek. Az összefoglaló közlemény elsődleges célja az elmúlt években leírt patofiziológiai és klinikai jellemzők, terápiás megfontolások és irodalmi újdonságok bemutatása. Orv. Hetil., 2016, 157(33), 1304–1313.

  • 1

    Global Strategy for Asthma Management and Prevention (GINA) 2015. http://www.ginaasthma.org

  • 2

    Magyar, P., Losonczy, G.: Bronchial asthma. In: Magyar, P., Losonczy, G. (eds.): Handbook of pulmonology. [Asthma bronciale. In: Magyar, P., Losonczy, Gy. (szerk.): A pulmonológia kézikönyve.] Medicina Könyvkiadó, Budapest, 2012. [Hungarian]

  • 3

    Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016. http://www.goldcopd.com

  • 4

    Buist, A. S., McBurnie, M. A., Vollmer, W. M., et al.: International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet, 2007, 370(9589), 741–750.

  • 5

    Fabbri, L. M., Romagnoli, M., Corbetta, L., et al.: Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 2003, 167(3), 418–424.

  • 6

    Lange, P., Parner, J., Vestbo, J., et al.: A 15 year follow-up study of ventilatory function in adults with asthma. N. Engl. J. Med., 1998, 339(17), 1194–2000.

  • 7

    Müller, V., Gálffy, G., Orosz, M., et al.: Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. Int. J. Chron. Obstruct. Pulmon. Dis., 2016, 11(1), 93–101.

  • 8

    Miravitlles, M., Alcázar, B., Alvarez, F. J., et al.: What pulmonologist think about the asthma-COPD overlap syndrome. Int. J. Chron. Obstruct. Pulmon. Dis., 2015, 10(1), 1321–1330.

  • 9

    Gibson, P. G., Simpson, J. L.: The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax, 2009, 64(8), 728–735.

  • 10

    De Marco, R., Pesce, G., Marcon, A., et al.: The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS ONE, 2013, 8(5), e62985.

  • 11

    Pleasants, R. A., Ohar, J. A., Croft, J. B., et al.: Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment. COPD, 2014, 11(3), 256–266.

  • 12

    Diaz-Guzman, E., Khosravi, M., Mannino, D. M.: Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD, 2011, 8(6), 400–407.

  • 13

    Soler-Cataluna, J. J., Cosío, B., Izquierdo, J. L., et al.: Consensus document on the overlap phenotype COPD-asthma in COPD. Arch. Broncopneumol., 2012, 48(9), 331–337.

  • 14

    Global Initiative for Asthma (GINA), Global Initiative for Chronic Obstructive Lung Disease (GOLD). Asthma, COPD, and asthma-COPD overlap syndrome. 2014. http://www.goldcopd.org/asthma-copd-overlap.html

  • 15

    Gerhardsson de Verdier, M., Andersson, M., Kern, D. M., et al.: Asthma and chronic obstructive pulmonary disease overlap syndrome: doubled costs compared with patients with asthma alone. Value Health, 2015, 18(6), 759–766.

  • 16

    Rhee, C. K., Yoon, H. K., Yoo, K. H., et al.: Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD, 2014, 11(2), 163–170.

  • 17

    Orie, N. G., Sluiter, H. J. (eds.): Bronchitis: an international symposium. Royal van Gorcum, Assen, Netherlands, 1962.

  • 18

    Postma, D. S., Weiss, S. T., van den Bergee, M., et al.: Revisiting the Dutch hypothesis. J. Allergy Clin. Immunol., 2015, 136(3), 521–529.

  • 19

    Orie, N. G.: The Dutch Hypothesis. Chest, 2000, 117(5 Suppl. 1), 299S.

  • 20

    Kaneko, Y., Yatagai, Y., Yamada, H., et al.: The search for common pathways underlying asthma and COPD. Int. J. Chron. Obstruct. Pulmon. Dis., 2013, 8, 65–78.

  • 21

    Hardin, M., Cho, M., McDonald, M. L., et al.: The clinical and genetic features of the COPD-asthma overlap syndrome. Eur. Respir. J., 2014, 44(2), 341–350.

  • 22

    Smolonska, J., Koppelman, G. H., Wijmenga, C., et al.: Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis. Eur. Respir. J., 2014, 44(4), 860–872.

  • 23

    Carpagnano, G. E., Lacedonia, D., Malerba, M., et al.: Analysis of mitochondrial DNA alteration in new phenotype ACOS. BMC Pulm. Med., 2016, 16(1), 31.

  • 24

    Gibson, P. G., McDonald, V. M.: Asthma-COPD overlap 2015: now we are six. Thorax, 2015, 70(7), 683–691.

  • 25

    Mauad, T., Dolhnikoff, M.: Pathologic similiraties and differences between asthma and chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med., 2008, 14(1), 31–38.

  • 26

    Ravensberg, A. J., Slats, A. M., van Wetering, S., et al.: CD8(+) T cells characterize early smoking-related airway pathology in patients with asthma. Respir. Med., 2013, 107(7), 959–966.

  • 27

    Moore, W. C., Hastie, A. T., Li, X., et al.: Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J. Allergy Clin. Immunol., 2014, 133(6), 1557–1563.e5.

  • 28

    Saha, S., Brightling, C. E.: Eosinophilic airway inflammation in COPD. Int. J. Chron. Obstruct. Pulmon. Dis., 2006, 1(1), 39–47.

  • 29

    Barker, B. L., Brightling, C. E.: Phenotyping the heterogenity of chronic obstructive pulmonary disease. Clin. Sci. (Lond.), 2013, 124(6), 371–387.

  • 30

    Brightling, C. E., Monteiro, W., Ward, R., et al.: Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet, 2000, 356(9240), 1480–1485.

  • 31

    Pascoe, S., Locantore, N., Dransfield, M. T., et al.: Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir. Med., 2015, 3(6), 435–442.

  • 32

    Singh, D., Kolsum, U., Brightling, C. E., et al.: Eosinophilic inflammation is COPD: prevalence and clinical characteristics. Eur. Respir. J., 2014, 44(6), 1697–1700.

  • 33

    Vestbo, J., Anderson, W., Coxson, H. O., et al.: Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur. Respir. J., 2008, 31(4), 869–873.

  • 34

    Postma, D. S., Rabe, K. F.: The asthma-COPD overlap syndrome. N. Engl. J. Med., 2015, 373(13), 1241–1249.

  • 35

    Postma, D. S., Reddel, H. K., ten Hacken, N. H., et al.: Asthma and chronic obstructive pulmonary disease: similarities and differences. Clin. Chest Med., 2014, 35(1), 143–156.

  • 36

    Papi, A., Romagnoli, M., Baraldo, S., et al.: Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 2000, 162(5), 1773–1777.

  • 37

    D’Silva, L., Hassan, N., Wang, H. Y., et al.: Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice. Can. Respir. J., 2011, 18(3), 144–148.

  • 38

    Van den Berge, M., Aalbers, R.: The asthma-COPD overlap syndrome: how is it defined and what are its clinical implications? J. Asthma Allergy, 2016, 9, 27–35.

  • 39

    American Thoracic Society: Standardization of spirometry. 1994 update. Am. J. Resp. Crit. Care Med., 1995, 152(3), 1107–1136. Standardization of spirometry. 1994 update.

  • 40

    Tashkin, D. P., Celli, B., Decramer, M., et al.: Bronchodilator responsiveness in patients with COPD. Eur. Respir. J., 2008, 31(4), 742–750.

  • 41

    Calverley, P. M., Albert, P., Walker, P. P.: Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations. Lancet Respir. Med., 2013, 1(7), 564–573.

  • 42

    Alshabanat, A., Zafari, Z., Albanyan, O., et al.: Asthma and COPD overlap syndrome (ACOS): A systematic review and meta analysis. PLoS ONE, 2015,10(9), e0136065.

  • 43

    Menezes, A. M., Montes de Oca, M., Pérez-Padilla, R., et al.: Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest, 2014, 145(2), 297–304.

  • 44

    Kitaguchi, Y., Komatsu, Y., Fujimoto, K., et al.: Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int. J. Chron. Obstruct. Pulmon. Dis., 2012, 7, 283–289.

  • 45

    O’Byrne, P. M., Postma, D. S.: The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 1999, 159(Suppl. 2), S41–S63.

  • 46

    Van den Berge, M., Kerstjens, H. A., Meijer, R. J., et al.: Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am. J. Respir. Crit. Care Med., 2001, 164(7), 1127–1132.

  • 47

    Rijcken, B., Schouten, J. P., Weiss, S. T., et al.: The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample. Am. Rev. Respir. Dis., 1987, 136(1), 62–68.

  • 48

    Tashkin, D. P., Altose, M. D., Connett, J. E., et al.: Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am. J. Respir. Crit. Care Med., 1996, 153(6), 1802–1811.

  • 49

    Tashkin, D. P., Altose, M. D., Bleecker, E. R., et al.: The Lung Health Study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. Am. Rev. Respir. Dis., 1992, 145(2 Pt 1), 301–310.

  • 50

    Lapperre, T. S., Snoeck-Stroband, J. B., Gosman, M. M., et al.: Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med., 2009, 151(8), 517–527.

  • 51

    Louie, S., Zeki, A. A., Schivo, M., et al.: The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev. Clin. Pharmacol., 2013, 6(2), 197–219.

  • 52

    Matsumoto, K., Seki, N., Fukuyama, S., et al.: Prevalence of asthma with airflow limitation, COPD, and COPD with variable airflow limitation in older subjects in a general Japanese population: the Hisayama study. Respir. Investig., 2015, 53(1), 22–29.

  • 53

    Cosio, B. G., Soriano, J. B., López-Campos, J. L., et al.: Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest, 2016, 149(1), 45–52.

  • 54

    Bujarski, S., Parulekar, A. D., Sharafkhaneh, A., et al.: The asthma COPD overlap syndrome (ACOS). Curr. Allergy Asthma Rep., 2015, 15(3), 1–9.

  • 55

    Koblizek, V., Chlumsky, J., Zindr, V., et al.: Chronic obstructive pulmonary disease: official diagnosis and treatment guidelines of the Czech Pneumological and Physiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 2013, 157(2), 189–201.

  • 56

    Nielsen, M., Barnes, C. B., Ulrik, C. S.: Clinical characteristics of the asthma-COPD overlap syndrome – a systematic review. Int. J. Chron. Obstruct. Pulmon. Dis., 2015, 10(1), 1443–1454.

  • 57

    Suzuki, T., Tada, Y., Kawata, N., et al.: Clinical, physiological, and radiological features of asthma-chronic obstructive pulmonary disease overlap syndrome. Int. J. Chron. Obstruct. Pulmon. Dis., 2015, 10, 947–954.

  • 58

    Knauppi, P., Kupiainen, H., Lindqvist, A., et al.: Overlap syndrome of asthma and COPD predicts low quality of life. J. Asthma, 2011, 48(3) 279–285.

  • 59

    Miravitlles, M., Soriano, J. B., Ancochea, J., et al.: Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir. Med., 2013, 107(7), 1053–1060.

  • 60

    Odler, B., Ivancsó, I., Somogyi, V., et al.: Vitamin D deficiency is associated with impaired disease control in asthma-COPD overlap syndrome patients. Int. J. Chron. Obstr. Pulmon. Dis., 2015, 10, 2017–2025.

  • 61

    McDonald, V. M., Higgins, I., Gibson, P. G.: Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges. Drugs Aging, 2013, 30(1), 1–17.

  • 62

    McDonald, V. M., Gibson, G. B.: Exacerbations of severe asthma. Clin. Exp. Allergy, 2012, 42(5), 670–677.

  • 63

    Gibson, P. G., McDonald, V. M., Marks, G. B.: Asthma in the older adult. Lancet, 2010, 376(9743), 803–813.

  • 64

    Van Boven, J. F., Román-Rodríguez, M., Palmer, J. F., et al.: Comorbidome, pattern and impact of asthma-COPD overlap syndrome (ACOS) in real life. Chest, 2016, 149(4), 1011–1020.

  • 65

    Chung, W. S., Lin, C. L., Kao, C. H.: Comparison of acute respiratory events between asthma-COPD overlap syndrome and COPD patients. Medicine (Baltimore), 2015, 94(17), e755.

  • 66

    Harada, T., Yamasaki, A., Fukushima, T., et al.: Causes of death in patients with asthma and asthma-chronic obstructive pulmonary disease overlap syndrome. Int. J. Chron. Obstruct. Pulmon. Dis., 2015, 10, 595–602.

  • 67

    Gelb, A. F., Yamamoto, A., Verbeken, E. K., et al.: Unraveling the pathophysiology of the asthma-COPD overlap syndrome: unsuspected mild centrilobular emphysema is responsible for loss of lung elastic recoil in never smokers with asthma with persistent expiratory airflow limitation. Chest, 2015, 148(2), 313–320.

  • 68

    Hardin, M., Silverman, E. K., Barr, R. G., et al.: The clinical features of the overlap between COPD and asthma. Respir. Res., 2011, 12(1), 127.

  • 69

    Gao, Y., Zhai, X., Li, K., et al.: Asthma COPD overlap syndrome on CT densitometry: A distinct phenotype from COPD. COPD, 2016. Jan 8. [Epub ahead of print]

  • 70

    Welte, T., Miravitlles, M., Hernandez, P., et al.: Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 2009, 180(8), 741–750.

  • 71

    Müller, V., Tamási, L., Somfay, A., et al.: Differences of various inhaler devices with same active compounds for the treatment of obstructive lung diseases. [Az eltérő inhalációs eszközből adagolt azonos hatóanyagú készítmények közötti különbségek.] Med. Thor., 2012, 65(5), 329–335. [Hungarian]

  • 72

    National Health Insurance Fund: The list of the prescipton authorized persons for accentuated indication linked medications. [Országos Egészségbiztosítási Pénztár: Az emelt, kiemelt indikációhoz kötött támogatási kategóriába tartozó gyógyszerek, indikációs területek és a felírásra jogosultak köre.] http://www.oep.hu//data/cms1011838/EU_tamogatasi_lista__2016_05_01_.pdf [Hungarian]

  • 73

    National Health Insurance Fund: Financing protocol. [Országos Egészségbiztosítási Pénztár: Finanszírozási protokoll.] http://www.kozlonyok.hu/nkonline/MKPDF/hiteles/MK15210.pdf [Hungarian]

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jan 2021 0 17 22
Feb 2021 0 10 15
Mar 2021 0 23 24
Apr 2021 0 15 20
May 2021 0 11 12
Jun 2021 0 9 16
Jul 2021 0 0 0